Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: In vitro evaluation

Drug Development and Industrial Pharmacy

Volumn 36, Issue 5, 2010, Pages 539-546

  Lu, Zhilei ^a   Chen, Weiyang ^a   Hamman, Josias H ^a  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Chitosan; Controlled release; Interpolyelectrolyte complex; Matrix system; Polycarbophil

Indexed keywords

CHITOSAN; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLCELLULOSE; KETOPROFEN; POLYCARBOPHIL; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFUSION; DRUG SOLUBILITY; IN VITRO STUDY; POWDER; TABLET FORMULATION;

ACRYLIC RESINS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG EVALUATION, PRECLINICAL; PHARMACEUTICAL PREPARATIONS; POLYMERS; RANDOM ALLOCATION; SOLUBILITY; WATER;

EID: 77952616547     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903315579     Document Type: Article

References (29)

1. Mandal TK. (2000). Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm, 50: 337-43.
2. Jantzen GM, Robinson JR. (2002). Sustained- and controlledrelease drug-delivery systems. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Marcel Dekker, Inc., 501-28.
3. Collet J, Moreton C. (2002). Modified release peroral dosage form. In: Aulton ME, ed. Pharmaceutics the science of dosage form design. Edinburgh: Churchill Livingstone, 289-306.
4. Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: Gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today, 3: 198-204.
5. Jamzad S, Fassihi R. (2006). Development of a controlled release low dose class II drug-Glipizide. Int J Pharm, 312: 24-32.
6. Colombo P. (1993). Swelling-controlled release in hydrogel matrices for oral route. Adv Drug Deliv Rev, 11: 37-57. (Pubitemid 23257482)
7. Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxylpropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48: 139-57.
8. Ford JL, Rubinstein MH, McCaul F, Hogan JE, Edgar PJ. (1987). Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxylpropyl methylcellulose matrix tablets. Int J Pharm, 40: 223-34.
9. Rao K V R, Padmalatha Devi K, Buri P. (1990). Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J Control Release, 12: 133-41.
10. Tahara K, Yamamoto K, Nishihata T. (1995). Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxylpropylmethylcellulose 2910. J Control Release, 35: 59-66.
11. Reynolds TD, Gehrke SH, Hussain AS, Shenouda LS. (1998). Polymer erosion and drug release characterization of hydroxylpropyl methylcellulose matrices. J Pharm Sci, 87: 1115-23.
12. Siepmann J, Kranz H, Bodmeier R, Peppas NA. (1999). HPMC matrices for controlled drug delivery: A new model combining diffusion, swelling and dissolution mechanisms and predicting the release kinetics. Pharm Res, 16: 1748-56.
13. Peppas NA, Khare AR. (1993). Preparation, structure and diffusion behaviour of hydrogels in controlled release. Adv Drug Deliv Rev, 11: 1-35.
14. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. (2004). Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm, 57: 19-34. (Pubitemid 38058801)
15. Nam K, Watanabe J, Ishihara K. (2004). The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: Hydrogel dissolution and insulin release under neutral pH condition. Eur J Pharm Sci, 23: 261-70.
16. Moustafine RI, Kabanova TV, Kemenova VA, Van den Mooter G. (2005). Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release, 103: 191-8. (Pubitemid 40248571)
17. Paul W, Sharma CP. (2000). Chitosan, a drug carrier for the 21st century: A review. STP Pharm Sci, 10: 5-22.
18. Dumitriu S, Chornet E. (1998). Inclusion and release of proteins from polysaccharide-based polyion complexes. Adv Drug Deliv Rev, 31: 223-46.
19. ® L100-55 interpolyelectrolyte complexes for colonic drug delivery. J Control Release, 116: e36-7.
20. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2007). Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65: 215-32.
21. Lu Z, Chen W, Hamman JH. (2007). Chitosan-polycarbophil complexes in swellable matrix systems for controlled drug release. Curr Drug Deliv, 4: 257-63.
22. Lu Z, Chen W, Olivier EI, Hamman JH. (2008). Matrix polymeric excipients: Comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose. Drug Deliv, 15: 87-96.
23. Lu Z, Chen W, Hamman JH, Ni J, Zhai X. (2008). Chitosanpolycarbophil interpolyelectrolyte complex as an excipient for bioadhesive matrix systems to control macromolecular drug delivery. Pharm Dev Technol, 13: 37-47.
24. United States Pharmacopoeia 29 (USP). (2006). Rockville: United States Pharmacopeial Convention, Inc.
25. Ritger PL, Peppas NA. (1987). A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J Control Release, 5: 37-42.
26. Pillay V, Fassihi R. (1999). A new method for dissolution studies of lipid filled capsules employing nifedipine as a model drug. Pharm Res, 16: 333-8.
27. Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60: 110-1.
28. Reppas C, Nicolaides E. (2000). Analysis of drug dissolution data. In: Dressman JB, Lennernäs H, eds. Oral drug absorption prediction and assessment. New York: Marcel Dekker, Inc., 229-54.
29. Sousa JJ, Sousa A, Moura MJ, Podczeck F, Nowton JM. (2002). The influence of core materials and film coating on the drug release from coated pellets. Int J Pharm, 233: 111-22. (Pubitemid 34230423)